Allen Cheng
@peripatetical.bsky.social
1.1K followers 99 following 45 posts
Infectious diseases physician, epidemiologist. Melbourne, Australia.
Posts Media Videos Starter Packs
Pinned
peripatetical.bsky.social
Allen Yung's Golden Rules of ID. Copied over from the Other Place for @kottonnelson.bsky.social #IDSky
peripatetical.bsky.social
Congratulations to Steve Tong, Josh Davis and the huge SNAP team (including Monash Health). Clear outcome that cefazolin is less nephrotoxic than flucloxacillin for MSSA, and pencillin is better for PSSA. @steventong.bsky.social @gurujosh.bsky.social
erinmccreary.bsky.social
@steventong.bsky.social presents the results of the PSSA domain of the SNAP 🫰 trial - the worlds largest trial of staph aureus bacteremia - at #ESCMID2025

fluclox resulted in higher mortality and more AKI compared to penicillin for PSSA
peripatetical.bsky.social
Looks like PubMed is down - not sure if this is a temporary outage or something more sinister. Europe PMC is an alternative search engine for medical literature that is publicly accessible. europepmc.org
Europe PMCHome - Europe PMC
Europe PMC is an archive of life sciences journal literature.
europepmc.org
Reposted by Allen Cheng
gurujosh.bsky.social
Great list @absteward.bsky.social! Mine is coming soon (limited to 10)
absteward.bsky.social
🔥🔥 NEW 🔥🔥
Year In Review: Top Infectious Diseases Articles From 2024
Our new post, a great collaboration with my friend
🌟 @idstewardship.bsky.social
1️⃣6️⃣⚡️🆔 RCTs
7️⃣Syst Reviews/Meta
3️⃣🌏Guidelines ✨️Wiki_Guidelines
#idsky #EMIMCC #medsky #utisky
EnJoy
Share plz!
www.idstewardship.com/year-review-...
Year In Review: Top Infectious Diseases Articles From 2024
In this article a selection of notable peer-reviewed publications from 2024 are provided. Article Selection by: Bassam Ghanem, Pharm.D., MS, BCPS Article Construction by: Timothy P. Gauthier, Pharm.D....
www.idstewardship.com
peripatetical.bsky.social
Paul Sax's "oh wow" moments in HIV: AZT during pregnancy reduces vertical transmission; triple ARVs improve survival; integrase inhibitors as effective salvage therapy; PrEP is very effective; undetectable = untransmissible and now 6 monthly lenacapravir PReP is 100% effective
peripatetical.bsky.social
Not my area of expertise, but I understand there are restrictions on the use of the Individual Healthcare Identifier so that it can't be used in linkage. But I could be wrong - others might know.
peripatetical.bsky.social
Very annoying when you’re writing a manuscript - can’t easily find/replace to change full stops to interpuncts. I understand it’s a historical anachronism, like the New Yorker using diaereses (coöperation”) en.m.wikipedia.org/wiki/Interpu...
Interpunct - Wikipedia
en.m.wikipedia.org
peripatetical.bsky.social
My father's family were originally rice farmers in China, and I ended up doing my PhD on melioidosis, a disease of rice farmers, partly based in Thailand where many of his siblings moved to (and where my cousin is an infectious diseases physician).
peripatetical.bsky.social
C is the Schrödinger's result - simultaneously inferior and non-inferior.
peripatetical.bsky.social
I've been off social media mostly for almost three years, was enticed back by Tony Korman, and tentitively wading back in!
peripatetical.bsky.social
Supports routinely using 7 days of treatment in bacteraemia (other than S aureus, fungaemia, and if there is a definite indication for longer eg endocarditis)
peripatetical.bsky.social
90 day mortality was *lower* in 7 day group (14.5%) vs 14 day group (16.1%); met non-inferiority criteria
There were no major differences between shorter/longer groups in subgroups, i8ncluding ICU, APACHE-II >25, by site or pathogen.
peripatetical.bsky.social
Broad variety of infection sites but majority gram neg (71%); clear separation in duration between shorter group (median 8 days) vs longer duration group (median 14 days)
peripatetical.bsky.social
It included ICU patients (55% of enrolled patients) but notably excluded immunocompromised, S aureus, candida, deep infection (eg endocarditis).
peripatetical.bsky.social
This was a large trial (n=3608) at 74 hospitals in 7 countries. (COI: The Australian arm was co-ordinated from Monash by Ben Rogers). It was a non inferiority, 7 vs 14 days of treatment; primary outcome 90 day mortality.
Reposted by Allen Cheng
sonkoning.bsky.social
Lessons from practice for immunocompromised hosts by Dr Ai Li Yeo and A/Prof Claire Dendle
#ForbesWeek #IDSky
1. There can be more than two pathologies in immunocompromised patients
peripatetical.bsky.social
Thanks for coming to Melbourne! It's been an honour to have you join our ID community here and benefit from your expertise.
peripatetical.bsky.social
28. In community-acquired infection, resistant organisms do not cause more severe illness than their sensitive counterparts. The only reason for using broader than usual therapy is when you (and the patient) cannot afford to be wrong.
peripatetical.bsky.social
27. When you suspect bacteraemia, do not wait for the patient’s temperature to go up before doing blood cultures.
peripatetical.bsky.social
26. In patients with unexplained neurological features, think of the five great infective mimics: HIV, syphilis, tuberculosis, Lyme disease (with epidemiological history), Whipple’s disease.
peripatetical.bsky.social
25. Bacterial aortitis needs to be excluded in a patient who develops abdominal pain or back pain within weeks of an episode of diarrhoea.
peripatetical.bsky.social
24. Remember that Listeria monocytogenes meningoencephalitis can masquerade clinically as herpes simplex encephalitis.
peripatetical.bsky.social
23. Avoid the term “atypical pneumonia” in children, adults over the age of 50 years, the immunocompromised, the severely ill, or patients with diffuse bilateral interstitial pulmonary infiltrates.